Differential response to risperidone in schizophrenia patients by KCNH2Genotype and drug metabolizer status

- Heide, Juliane, Zhang, Fengyu, Bigos, Kristin L., Mann, Sefan A., Carr, Vaughan J., Weickert, Cynthia Shannon, Green, Melissa J., Weinberger, Daniel R., Vandenberg, Jamie I.

Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis

- Daniel, James A., Chau, Ngoc, Haucke, Volker, McCluskey, Adam, Robinson, Phillip J., Abdel-Hamid, Mohammed K., Hu, Lingbo, von Kleist, Lisa, Whiting, Ainslie, Krishnan, Sai, Maamary, Peter, Joseph, Shannon R., Simpson, Fiona

Prolonged QT risk assessment in antipsychotic overdose usingthe QT nomogram

- Berling, Ingrid, Isbister, Geoffrey K.

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication

- Kumarasinghe, Nishantha, Beveridge, Natalie J., Gardiner, Erin, Scott, Rodney J., Yasawardene, Surangi, Perera, Antoinette, Mendis, Jayan, Suriyakumara, Kanishka, Schall, Ulrich, Tooney, Paul A.

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine

- Santarelli, Danielle M., Liu, Bing, Duncan, Carlotta E., Beveridge, Natalie J., Tooney, Paul A., Schofield, Peter R., Cairns, Murray J.

Post-transcriptional gene regulation in schizophrenia, antipsychotic drug treatment and the developing brain

- Santarelli, Danielle Maree

Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: effects of antipsychotic drugs

- Weidenhofer, Judith, Scott, Rodney J., Tooney, Paul A.